| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a802857a5b74d51ec759b52227105e47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0931241d9441d023245580a92141bf68 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L2-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 |
| filingDate |
2016-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b4a827b842ca18de3e317c8333eafa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4161521c258881cf27d733d1d2b823e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52f1e6df598a166cc9da54328f74e34e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e19b9d8babb7aee1c4053e9635a30cbf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cab82ec8bb0a007f6b99bd2916f150c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcbe4200077e7465d07c31023482a456
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01e07543ce9d2f07af0b7f175ddf53e3 |
| publicationDate |
2020-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10610558-B2 |
| titleOfInvention |
Prophylactic and/or therapeutic agent for NAFLD/NASH |
| abstract |
The present invention provides a prophylactic and/or therapeutic agent for non-alcoholic fatty liver disease (NAFLD), and particularly non-alcoholic steatohepatitis (NASH) comprising an ume (Japanese apricot) juice concentrate or a processed product thereof. The prophylactic and/or therapeutic agent is obtained by utilizing a component contained in a plant or a processed product thereof, and hence is safe and easily taken. It has been confirmed that when the ume juice concentrate or the processed product thereof is orally administered to a streptozocin (STZ)-induced NAFLD model mouse or an STZ-induced NASH model mouse, liver fibrogenesis can be reduced. |
| priorityDate |
2015-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |